KYMR Long Put Strategy
KYMR (Kymera Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
KYMR (Kymera Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $9.38B, a beta of 1.96 versus the broader market, a 52-week range of 39.713-130.05, average daily share volume of 720K, a public-listing history dating back to 2020, approximately 238 full-time employees. These structural characteristics shape how KYMR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.96 indicates KYMR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on KYMR?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
KYMR snapshot
As of August 14, 2026, spot at $117.47, ATM IV 44.80%, IV rank 1.00%, expected move 12.84%. The long put on KYMR below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on KYMR specifically: KYMR IV at 44.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a KYMR long put, with a market-implied 1-standard-deviation move of approximately 12.84% (roughly $15.09 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KYMR expiries trade a higher absolute premium for lower per-day decay. Position sizing on KYMR should anchor to the underlying notional of $117.47 per share and to the trader's directional view on KYMR stock.
KYMR long put setup
The KYMR long put below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KYMR at $117.47 on that close, the first option leg uses a $115.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KYMR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KYMR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $115.00 | $5.60 |
KYMR long put risk and reward
- Net Premium / Debit
- -$560.00
- Max Profit (per contract)
- $10,939.00
- Max Loss (per contract)
- -$560.00
- Breakeven(s)
- $109.40
- Risk / Reward Ratio
- 19.534
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
KYMR long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on KYMR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$10,939.00 |
| $25.98 | -77.9% | +$8,341.78 |
| $51.95 | -55.8% | +$5,744.57 |
| $77.93 | -33.7% | +$3,147.35 |
| $103.90 | -11.6% | +$550.14 |
| $129.87 | +10.6% | -$560.00 |
| $155.84 | +32.7% | -$560.00 |
| $181.82 | +54.8% | -$560.00 |
| $207.79 | +76.9% | -$560.00 |
| $233.76 | +99.0% | -$560.00 |
When traders use long put on KYMR
Long puts on KYMR hedge an existing long KYMR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying KYMR exposure being hedged.
KYMR thesis for this long put
The market-implied 1-standard-deviation range for KYMR extends from approximately $102.38 on the downside to $132.56 on the upside. A KYMR long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long KYMR position with one put per 100 shares held. Current KYMR IV rank near 1.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KYMR at 44.80%. As a Healthcare name, KYMR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KYMR-specific events.
KYMR long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KYMR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KYMR alongside the broader basket even when KYMR-specific fundamentals are unchanged. Long-premium structures like a long put on KYMR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current KYMR chain quotes before placing a trade.
Frequently asked questions
- What is a long put on KYMR?
- A long put on KYMR is the long put strategy applied to KYMR (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With KYMR stock at $117.47 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed KYMR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are KYMR long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the KYMR long put priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 44.80%), the computed maximum profit is $10,939.00 per contract and the computed maximum loss is -$560.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a KYMR long put?
- The breakeven for the KYMR long put priced on this page is roughly $109.40 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The KYMR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on KYMR?
- Long puts on KYMR hedge an existing long KYMR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying KYMR exposure being hedged.
- How does current KYMR implied volatility affect this long put?
- KYMR ATM IV is at 44.80% with IV rank near 1.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.